FASN and prostate carcinoma: Akt isoform specificity has yet to be extensively studied in breast cancer in relation to FASN, although prostate cancer studies have revealed a relationship between Akt3 and FASN involving the two as downstream effectors of peroxisome proliferator-activated receptor gamma (PPARG) activation [154].